15/10/02说明:此前论坛服务器频繁出错,现已更换服务器。今后论坛继续数据库备份,不备份上传附件。

肝胆相照论坛

 

 

肝胆相照论坛 论坛 学术讨论& HBV English 存档 1 慢性感染为什么会产生免疫耐受?
查看: 2438|回复: 5

慢性感染为什么会产生免疫耐受? [复制链接]

Rank: 10Rank: 10Rank: 10

现金
834 元 
精华
21 
帖子
5573 
注册时间
2001-10-6 
最后登录
2023-11-6 

荣誉之星

1
发表于 2006-10-13 15:16
慢性感染为什么会产生免疫耐受?

下面的成果也可能对治疗乙肝慢性感染起到重要作用。

-----------------------------------------------------------------------------
http://www.most.gov.cn/gnwkjdt/t20060829_35688.htm
国内外科技动态

艾滋病病毒破坏免疫系统机理查明

    由多国科学家组成的研究小组日前表示,他们发现了艾滋病病毒通过向T细胞“弹射”分子开关,并关闭T细胞免疫功能的机理。同时,试管中的实验表明,他们能以阻断分子开关通道的方法重新恢复T细胞的功能。
 
  所说的分子开关,也称为抑制开关(PD-1)。T细胞是淋巴细胞的一种,在免疫应答中扮演着重要的角色。在T淋巴细胞分类中,CD4代表T辅助细胞,而 CD8代表T抑制细胞和T杀伤细胞。CD4+T淋巴细胞是艾滋病病毒感染的主要靶细胞,而其本身又是免疫系统的中心细胞;CD8+T淋巴细胞是免疫反应的效应细胞。
 
  据《自然》杂志网站介绍,科研小组对艾滋病病毒携带者的血样进行实验发现,采用抗体阻断血液细胞中PD-1通道,可以极大地提高艾滋病病毒特异性CD8细胞针对病毒抗原而增生扩散的能力,以及提高CD8细胞中γ—干扰素的数量。同时,阻断PD-1通道还能促进病毒特异性 CD4细胞的增殖,这表明曾被“关闭”的T细胞恢复到了正常状态。
 
  该研究小组人员由来自美国麻省总医院的帕特瑞斯艾滋病研究中心、南非夸祖鲁-纳塔尔大学和其他研究机构组成。小组带头人、帕特瑞斯艾滋病研究中心主任布鲁斯•沃克表示,由于阻断PD-1分子开关通道的药物目前已经存在,因此可以很快让新药进入临床试验。然而,他同时警告说,这些药物可能会引起十分严重的副作用,如导致人体免疫系统攻击自身身体的自体免疫反应。
 
  沃克他们发现艾滋病病毒“关闭”T细胞功能的机制,得益于艾莫瑞大学医学院拉菲•阿莫德博士和哈佛医学院癌症研究所戈登•弗里曼博士的研究成果。早些时候,阿莫德他们发现部分慢性的病毒感染通过开启T细胞的抑制开关PD-1制约了T细胞。此外,他们还表示,在实验鼠身上,采用阻断PD-1通道的方式,能够恢复T细胞的功能并降低了其血液中病毒的数量。(科技日报)

[此贴子已经被作者于2006-10-13 2:18:12编辑过]

Rank: 10Rank: 10Rank: 10

现金
834 元 
精华
21 
帖子
5573 
注册时间
2001-10-6 
最后登录
2023-11-6 

荣誉之星

2
发表于 2006-10-13 15:27
一些相关文摘。

这里列出艾滋病相关。
肝炎研究也有人进行。
-----------------------------------------------------------------------------
Nat Med. 2006 Nov;12(10):1198-1202. Epub 2006 Aug 20.Click here to read  Links
    Upregulation of PD-1 expression on HIV-specific CD8(+) T cells leads to reversible immune dysfunction.
   [1] Laboratoire d'Immunologie, Centre de Recherche du Centre Hospitalier de l'Universite de Montreal (CR-CHUM) Saint-Luc, 264 Rene Levesque Est, Montreal, Quebec H2X1P1, Canada. [2] Laboratoire d'Immunologie, Departement de Microbiologie et d'Immunologie, Universite de Montreal, Quebec, Canada. [3] INSERM U743, CR-CHUM, Universite de Montreal, 264 Rene Levesque Est, Montreal, Quebec H2X1P1, Canada.

    The engagement of programmed death 1 (PD-1) to its ligands, PD-L1 and PD-L2, inhibits proliferation and cytokine production mediated by antibodies to CD3 (refs. 5,6,7). Blocking the PD-1-PD-L1 pathway in mice chronically infected with lymphocytic choriomeningitis virus restores the capacity of exhausted CD8(+) T cells to undergo proliferation, cytokine production and cytotoxic activity and, consequently, results in reduced viral load. During chronic HIV infection, HIV-specific CD8(+) T cells are functionally impaired, showing a reduced capacity to produce cytokines and effector molecules as well as an impaired capacity to proliferate. Here, we found that PD-1 was upregulated on HIV-specific CD8(+) T cells; PD-1 expression levels were significantly correlated both with viral load and with the reduced capacity for cytokine production and proliferation of HIV-specific CD8(+) T cells. Notably, cytomegalovirus (CMV)-specific CD8(+) T cells from the same donors did not upregulate PD-1 and maintained the production of high levels of cytokines. Blocking PD-1 engagement to its ligand (PD-L1) enhanced the capacity of HIV-specific CD8(+) T cells to survive and proliferate and led to an increased production of cytokines and cytotoxic molecules in response to cognate antigen. The accumulation of HIV-specific dysfunctional CD8(+) T cells in the infected host could prevent the renewal of a functionally competent HIV-specific CD8(+) repertoire.

-----------------------------------------------------------------------------
 Nature. 2006 Sep 21;443(7109):350-4. Epub 2006 Aug 20.
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.

HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZulu Natal, Durban 4013, South Africa.

Functional impairment of T cells is characteristic of many chronic mouse and human viral infections. The inhibitory receptor programmed death 1 (PD-1; also known as PDCD1), a negative regulator of activated T cells, is markedly upregulated on the surface of exhausted virus-specific CD8 T cells in mice. Blockade of this pathway using antibodies against the PD ligand 1 (PD-L1, also known as CD274) restores CD8 T-cell function and reduces viral load. To investigate the role of PD-1 in a chronic human viral infection, we examined PD-1 expression on human immunodeficiency virus (HIV)-specific CD8 T cells in 71 clade-C-infected people who were naive to anti-HIV treatments, using ten major histocompatibility complex (MHC) class I tetramers specific for frequently targeted epitopes. Here we report that PD-1 is significantly upregulated on these cells, and expression correlates with impaired HIV-specific CD8 T-cell function as well as predictors of disease progression: positively with plasma viral load and inversely with CD4 T-cell count. PD-1 expression on CD4 T cells likewise showed a positive correlation with viral load and an inverse correlation with CD4 T-cell count, and blockade of the pathway augmented HIV-specific CD4 and CD8 T-cell function. These data indicate that the immunoregulatory PD-1/PD-L1 pathway is operative during a persistent viral infection in humans, and define a reversible defect in HIV-specific T-cell function. Moreover, this pathway of reversible T-cell impairment provides a potential target for enhancing the function of exhausted T cells in chronic HIV infection.
-----------------------------------------------------------------------------

这一篇文章最为重要,正是这个发现带来了一系列的突破。

Nature 439, 682-687 (9 February 2006) | doi:10.1038/nature04444; Received 1 August 2005; Accepted 21 November 2005; Published online 28 December 2005

Restoring function in exhausted CD8 T cells during chronic viral infection

Daniel L. Barber1, E. John Wherry2, David Masopust1, Baogong Zhu3, James P. Allison4, Arlene H. Sharpe5, Gordon J. Freeman3 and Rafi Ahmed1
Top of page
Abstract

Functional impairment of antigen-specific T cells is a defining characteristic of many chronic infections, but the underlying mechanisms of T-cell dysfunction are not well understood. To address this question, we analysed genes expressed in functionally impaired virus-specific CD8 T cells present in mice chronically infected with lymphocytic choriomeningitis virus (LCMV), and compared these with the gene profile of functional memory CD8 T cells. Here we report that PD-1 (programmed death 1; also known as Pdcd1) was selectively upregulated by the exhausted T cells, and that in vivo administration of antibodies that blocked the interaction of this inhibitory receptor with its ligand, PD-L1 (also known as B7-H1), enhanced T-cell responses. Notably, we found that even in persistently infected mice that were lacking CD4 T-cell help, blockade of the PD-1/PD-L1 inhibitory pathway had a beneficial effect on the 'helpless' CD8 T cells, restoring their ability to undergo proliferation, secrete cytokines, kill infected cells and decrease viral load. Blockade of the CTLA-4 (cytotoxic T-lymphocyte-associated protein 4) inhibitory pathway had no effect on either T-cell function or viral control. These studies identify a specific mechanism of T-cell exhaustion and define a potentially effective immunological strategy for the treatment of chronic viral infections.
-----------------------------------------------------------------------------

Rank: 9Rank: 9Rank: 9

现金
16903 元 
精华
帖子
6721 
注册时间
2006-9-20 
最后登录
2011-6-7 

管理员或超版 荣誉之星

3
发表于 2006-10-15 05:21
可还有突破?有无针对性的药物?
顺其自然

Rank: 10Rank: 10Rank: 10

现金
834 元 
精华
21 
帖子
5573 
注册时间
2001-10-6 
最后登录
2023-11-6 

荣誉之星

4
发表于 2006-10-19 21:26
从科研突破到药物出现有一定的时间。
这已经是一个非常重要的发现了。

意义在于。打破因为长期感染病毒产生的免疫耐受。让身体的卫士重新投入战斗。

Rank: 10Rank: 10Rank: 10

现金
834 元 
精华
21 
帖子
5573 
注册时间
2001-10-6 
最后登录
2023-11-6 

荣誉之星

5
发表于 2006-10-19 21:30
我是先了解到学术界普遍对下面这一篇文章高度评价。再在网上找一些相关文章以及中文翻译。

(Nature 439, 682-687 (9 February 2006) | doi:10.1038/nature04444; Received 1 August 2005; Accepted 21 November 2005; Published online 28 December 2005Restoring function in exhausted CD8 T cells during chronic viral infection)

Rank: 4

现金
1647 元 
精华
帖子
256 
注册时间
2006-5-10 
最后登录
2007-7-9 
6
发表于 2006-11-4 07:54
‹ 上一主题|下一主题

肝胆相照论坛

GMT+8, 2024-10-6 21:36 , Processed in 0.014322 second(s), 11 queries , Gzip On.

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.